Literature DB >> 22810087

Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences.

Annemiek B G Kwast1, Karin C G M Groothuis-Oudshoorn, Ilse Grandjean, Vincent K Y Ho, Adri C Voogd, Marian B E Menke-Pluymers, Maurice J C van der Sangen, Vivianne C G Tjan-Heijnen, Lambertus A Kiemeney, Sabine Siesling.   

Abstract

Invasive lobular breast cancer (ILC) is less common than invasive ductal breast cancer (IDC) and appears to have a distinct biology. Inconsistent findings regarding disease-free survival (DFS) are probably due to the fact that histologic type is related to hormone receptor status. This study aims to determine whether the type of the primary breast cancer histology is an independent prognostic factor for DFS, the risk pattern of loco-regional recurrences and distant metastases (DM), and whether it is a prognostic factor for the site of DM. All Dutch women diagnosed between 2003 and 2005 with ILC (n = 2,949) or IDC (n = 22,378) were selected from the Netherlands Cancer Registry. DFS was assessed using proportional hazard regression analysis. Compared to patients with IDC, those with ILC were significantly older and more likely to have more than three positive lymph nodes and have larger, better differentiated, more multifocal, and hormone receptor positive tumors (all P < 0.001). ILC was more likely to metastasize to the gastrointestinal organs and bones and less likely to the lung, central nervous system, and lymph nodes. Within the ER+PR+ and ER+PR- subgroups ILC was still more likely to metastasize to gastrointestinal organs and less likely to the lung. The timing of recurrence was correlated to hormone receptor status, independent of histological type. Highest risks were observed among ER-PR- patients within 2 years of surgery. Multivariable analysis showed that histological type is not an independent significant prognostic factor of DFS for the first 3 years post-surgery and thereafter (<3 years HR 0.91, 95 % CI 0.78-1.06, >3 years HR 1.07, 95 % CI 0.88-1.30). Histological type should not be considered an important prognostic factor for the risk and risk pattern of recurrences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810087     DOI: 10.1007/s10549-012-2160-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  Long-term Follow-up of Autologous Fat Transfer vs Conventional Breast Reconstruction and Association With Cancer Relapse in Patients With Breast Cancer.

Authors:  Todor Krastev; Arjen van Turnhout; Eline Vriens; Luc Smits; René van der Hulst
Journal:  JAMA Surg       Date:  2019-01-01       Impact factor: 14.766

2.  A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma.

Authors:  Nüvit Duraker; Semih Hot; Arzu Akan; Pınar Özay Nayır
Journal:  Eur J Breast Health       Date:  2020-01-01

3.  Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.

Authors:  Annemieke Witteveen; Annemiek B G Kwast; Gabe S Sonke; Maarten J IJzerman; Sabine Siesling
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

4.  The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.

Authors:  Fabio Zugni; Francesca Ruju; Paola Pricolo; Sarah Alessi; Monica Iorfida; Marco Angelo Colleoni; Massimo Bellomi; Giuseppe Petralia
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

5.  Meta-analysis of the oncological safety of autologous fat transfer after breast cancer.

Authors:  T K Krastev; S J Schop; J Hommes; A A Piatkowski; E M Heuts; R R W J van der Hulst
Journal:  Br J Surg       Date:  2018-06-05       Impact factor: 6.939

6.  Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer.

Authors:  Yaming Li; Peng Su; Yifei Wang; Hanwen Zhang; Yiran Liang; Ning Zhang; Xiaojin Song; Xiaoyan Li; Jie Li; Qifeng Yang
Journal:  Cancer Med       Date:  2019-12-09       Impact factor: 4.452

7.  The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches.

Authors:  Dorien Lobbezoo; Wilfred Truin; Adri Voogd; Rudi Roumen; Gerard Vreugdenhil; Marcus Wouter Dercksen; Franchette van den Berkmortel; Tineke Smilde; Agnes van de Wouw; Roel van Kampen; Johanna van Riel; Natascha Peters; Petronella Peer; Vivianne C G Tjan-Heijnen
Journal:  Oncotarget       Date:  2016-05-17

8.  Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.

Authors:  Zheling Chen; Jiao Yang; Shuting Li; Meng Lv; Yanwei Shen; Biyuan Wang; Pan Li; Min Yi; Xiao'ai Zhao; Lingxiao Zhang; Le Wang; Jin Yang
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

9.  Presence of circulating tumor cells is associated with metabolic-related variables in postoperative patients with early-stage breast cancer.

Authors:  Yumei Shi; Guochun Zhang; Yulei Wang; Chongyang Ren; Lingzhu Wen; Wenzhen Zhu; Xiaoqing Chen; Ning Liao
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.